[Experimental studies in vitro on the antituberculous activities of 27753RP (R.P), a semisynthetic derivative of griselimycine. III. Cross resistance of R.P].
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular / Q000494:pharmacology*; D000995:Antitubercular Agents / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000302:isolation & purification; D010455:Peptides / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D010455:Peptides; C028747:27753R.P.